Tofacitinib for the Treatment of Steroid-Induced Rosacea

PURPOSE: Conventional treatment suffers from a dilemma of poor efficacy. The clinical use of Janus kinase (JAK) inhibitors in the treatment of steroid-induced rosacea has rarely been explored. PATIENTS AND METHODS: We present a case of steroid-induced rosacea successfully treated with JAK inhibitor...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Tianhao, Wang, Henghong, Wang, Caiying, Hao, Pingsheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9701777/
https://www.ncbi.nlm.nih.gov/pubmed/36452437
http://dx.doi.org/10.2147/CCID.S392280

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9701777/
https://www.ncbi.nlm.nih.gov/pubmed/36452437
http://dx.doi.org/10.2147/CCID.S392280

Ejemplares similares